A BILL 
To amend title 38, United States Code, to direct the Sec-
retary of Veterans Affairs to adopt and implement a 
standard identification protocol for use in the tracking 
and procurement of biological implants by the Depart-
ment of Veterans Affairs, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Biological Implant 
4
Tracking and Veteran Safety Act of 2019’’. 
5
23:09 Jan 28, 2019
H547
2 
•HR 547 IH
SEC. 2. IDENTIFICATION AND TRACKING OF BIOLOGICAL 
1
IMPLANTS USED IN DEPARTMENT OF VET-
2
ERANS AFFAIRS MEDICAL FACILITIES. 
3
(a) IN GENERAL.—Subchapter II of chapter 73 of 
4
title 38, United States Code, is amended by adding at the 
5
end the following new section: 
6
‘‘§ 7330D. Identification and tracking of biological im-
7
plants 
8
‘‘(a) STANDARD IDENTIFICATION SYSTEM FOR BIO-
9
LOGICAL IMPLANTS.—(1) The Secretary shall adopt the 
10
unique device identification system developed for medical 
11
devices by the Food and Drug Administration under sec-
12
tion 519(f) of the Federal Food, Drug, and Cosmetic Act 
13
(21 U.S.C. 360i(f)), or implement a comparable standard 
14
identification system, for use in identifying biological im-
15
plants intended for use in medical procedures conducted 
16
in medical facilities of the Department. 
17
‘‘(2) In adopting or implementing a standard identi-
18
fication system for biological implants under paragraph 
19
(1), the Secretary shall permit a vendor to use any of the 
20
accredited entities identified by the Food and Drug Ad-
21
ministration as an issuing agency pursuant to section 
22
830.100 of title 21, Code of Federal Regulations, or any 
23
successor regulation. 
24
‘‘(b) BIOLOGICAL IMPLANT TRACKING SYSTEM.—(1) 
25
The Secretary shall implement a system for tracking the 
26
23:09 Jan 28, 2019
H547
3 
•HR 547 IH
biological implants described in subsection (a) from 
1
human donor or animal source to implantation. 
2
‘‘(2) The tracking system implemented under para-
3
graph (1) shall be compatible with the identification sys-
4
tem adopted or implemented under subsection (a). 
5
‘‘(3) The Secretary shall implement inventory con-
6
trols compatible with the tracking system implemented 
7
under paragraph (1) so that all patients who have re-
8
ceived, in a medical facility of the Department, a biological 
9
implant subject to a recall can be notified of the recall 
10
if, based on the evaluation by appropriate medical per-
11
sonnel of the Department of the risks and benefits, the 
12
Secretary determines such notification is appropriate. 
13
‘‘(c) CONSISTENCY WITH FOOD AND DRUG ADMINIS-
14
TRATION REGULATIONS.—To the extent that a conflict 
15
arises between this section and a provision of the Federal 
16
Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) 
17
or section 351 or 361 of the Public Health Service Act 
18
(42 U.S.C. 262 and 264) (including any regulations issued 
19
under such provisions), the provision of the Federal Food, 
20
Drug, and Cosmetic Act or Public Health Service Act (in-
21
cluding any regulations issued under such provisions) shall 
22
apply. 
23
‘‘(d) BIOLOGICAL IMPLANT DEFINED.—In this sec-
24
tion, the term ‘biological implant’ means any human cell, 
25
23:09 Jan 28, 2019
H547
4 
•HR 547 IH
tissue, or cellular or tissue-based product or animal prod-
1
uct— 
2
‘‘(1) under the meaning given the term ‘human 
3
cells, tissues, or cellular or tissue-based products’ in 
4
section 1271.3 of title 21, Code of Federal Regula-
5
tions, or any successor regulation; or 
6
‘‘(2) that is regulated as a device under section 
7
201(h) of the Federal Food, Drug, and Cosmetic 
8
Act (21 U.S.C. 321(h)).’’. 
9
(b) CLERICAL AMENDMENT.—The table of sections 
10
at the beginning of such chapter is amended by inserting 
11
after the item relating to section 7330C the following new 
12
item: 
13
‘‘7330D. Identification and tracking of biological implants.’’. 
(c) IMPLEMENTATION DEADLINES.— 
14
(1) STANDARD IDENTIFICATION SYSTEM.—The 
15
Secretary of Veterans Affairs shall adopt or imple-
16
ment the standard identification system for biologi-
17
cal implants required by subsection (a) of section 
18
7330C of title 38, United States Code, as added by 
19
subsection (a), with respect to biological implants 
20
described in— 
21
(A) subsection (d)(1) of such section, by 
22
not later than the date that is 180 days after 
23
the date of the enactment of this Act; and 
24
23:09 Jan 28, 2019
H547
5 
•HR 547 IH
(B) subsection (d)(2) of such section, in 
1
compliance with the compliance dates estab-
2
lished by the Food and Drug Administration 
3
under section 519(f) of the Federal Food, 
4
Drug, and Cosmetic Act (21 U.S.C. 360i(f)). 
5
(2) TRACKING SYSTEM.—The Secretary of Vet-
6
erans Affairs shall implement the biological implant 
7
tracking system required by section 7330C(b) of title 
8
38, United States Code, as added by subsection (a), 
9
by not later than the date that is 180 days after the 
10
date of the enactment of this Act. 
11
(d) REPORTING REQUIREMENT.— 
12
(1) IN
GENERAL.—If the biological implant 
13
tracking system required by section 7330C(b) of title 
14
38, United States Code, as added by subsection (a), 
15
is not operational by the date that is 180 days after 
16
the date of the enactment of this Act, the Secretary 
17
of Veterans Affairs shall submit to the Committee 
18
on Veterans’ Affairs of the Senate and the Com-
19
mittee on Veterans’ Affairs of the House of Rep-
20
resentatives a report explaining why the system is 
21
not operational for each month until such time as 
22
the system is operational. 
23
23:09 Jan 28, 2019
H547
6 
•HR 547 IH
(2) ELEMENTS.—Each report submitted under 
1
paragraph (1) shall include a description of the fol-
2
lowing: 
3
(A) Each impediment to the implementa-
4
tion of the system described in such paragraph. 
5
(B) Steps being taken to remediate each 
6
such impediment. 
7
(C) Target dates for a solution to each 
8
such impediment. 
9
SEC. 3. PROCUREMENT OF BIOLOGICAL IMPLANTS USED IN 
10
DEPARTMENT OF VETERANS AFFAIRS MED-
11
ICAL FACILITIES. 
12
(a) PROCUREMENT.— 
13
(1) IN GENERAL.—Subchapter II of chapter 81 
14
of title 38, United States Code, is amended by add-
15
ing at the end the following new section: 
16
‘‘§ 8129. Procurement of biological implants 
17
‘‘(a) IN GENERAL.—(1) The Secretary may procure 
18
biological implants of human origin only from vendors that 
19
meet the following conditions: 
20
‘‘(A) The vendor uses the standard identifica-
21
tion system adopted or implemented by the Sec-
22
retary under section 7330C(a) of this title and has 
23
safeguards to ensure that a distinct identifier has 
24
23:09 Jan 28, 2019
H547
7 
•HR 547 IH
been in place at each step of distribution of each bio-
1
logical implant from its donor. 
2
‘‘(B) The vendor is registered as required by 
3
the Food and Drug Administration under subpart B 
4
of part 1271 of title 21, Code of Federal Regula-
5
tions, or any successor regulation, and in the case of 
6
a vendor that uses a tissue distribution intermediary 
7
or a tissue processor, the vendor provides assurances 
8
that the tissue distribution intermediary or tissue 
9
processor is registered as required by the Food and 
10
Drug Administration. 
11
‘‘(C) The vendor ensures that donor eligibility 
12
determinations and such other records as the Sec-
13
retary may require accompany each biological im-
14
plant at all times, regardless of the country of origin 
15
of the donor of the biological material. 
16
‘‘(D) The vendor agrees to cooperate with all 
17
biological implant recalls conducted on the initiative 
18
of the vendor, on the initiative of the original prod-
19
uct manufacturer used by the vendor, by the request 
20
of the Food and Drug Administration, or by a statu-
21
tory order of the Food and Drug Administration. 
22
‘‘(E) The vendor agrees to notify the Secretary 
23
of any adverse event or reaction report it provides 
24
to the Food and Drug Administration, as required 
25
23:09 Jan 28, 2019
H547
8 
•HR 547 IH
by sections 1271.3 and 1271.350 of title 21, Code 
1
of Federal Regulations, or any successor regulation, 
2
or any warning letter from the Food and Drug Ad-
3
ministration issued to the vendor or a tissue proc-
4
essor or tissue distribution intermediary used by the 
5
vendor by not later than 60 days after the vendor 
6
receives such report or warning letter. 
7
‘‘(F) The vendor agrees to retain all records as-
8
sociated with the procurement of a biological implant 
9
by the Department for at least 10 years after the 
10
date of the procurement of the biological implant. 
11
‘‘(G) The vendor provides assurances that the 
12
biological implants provided by the vendor are ac-
13
quired only from tissue processors that maintain ac-
14
tive accreditation with the American Association of 
15
Tissue Banks or a similar national accreditation spe-
16
cific to biological implants. 
17
‘‘(2) The Secretary may procure biological implants 
18
of nonhuman origin only from vendors that meet the fol-
19
lowing conditions: 
20
‘‘(A) The vendor uses the standard identifica-
21
tion system adopted or implemented by the Sec-
22
retary under section 7330C(a) of this title. 
23
‘‘(B) The vendor is registered as an establish-
24
ment as required by the Food and Drug Administra-
25
23:09 Jan 28, 2019
H547
9 
•HR 547 IH
tion under sections 807.20 and 807.40 of title 21, 
1
Code of Federal Regulations, or any successor regu-
2
lation (or is not required to register pursuant to sec-
3
tion 807.65(a) of such title, or any successor regula-
4
tion), and in the case of a vendor that is not the 
5
original product manufacturer of such implants, the 
6
vendor provides assurances that the original product 
7
manufacturer is registered as required by the Food 
8
and Drug Administration (or is not required to reg-
9
ister). 
10
‘‘(C) The vendor agrees to cooperate with all bi-
11
ological implant recalls conducted on the initiative of 
12
the vendor, on the initiative of the original product 
13
manufacturer used by the vendor, by the request of 
14
the Food and Drug Administration, or by a statu-
15
tory order of the Food and Drug Administration. 
16
‘‘(D) The vendor agrees to notify the Secretary 
17
of any adverse event report it provides to the Food 
18
and Drug Administration as required under part 
19
803 of title 21, Code of Federal Regulations, or any 
20
successor regulation, or any warning letter from the 
21
Food and Drug Administration issued to the vendor 
22
or the original product manufacturer used by the 
23
vendor by not later than 60 days after the vendor 
24
receives such report or warning letter. 
25
23:09 Jan 28, 2019
H547
10 
•HR 547 IH
‘‘(E) The vendor agrees to retain all records as-
1
sociated with the procurement of a biological implant 
2
by the Department for at least 10 years after the 
3
date of the procurement of the biological implant. 
4
‘‘(3)(A) The Secretary shall procure biological im-
5
plants under the Federal Supply Schedules of the General 
6
Services Administration unless such implants are not 
7
available under such Schedules. 
8
‘‘(B) With respect to biological implants listed on the 
9
Federal Supply Schedules, the Secretary shall accommo-
10
date reasonable vendor requests to undertake outreach ef-
11
forts to educate medical professionals of the Department 
12
about the use and efficacy of such biological implants. 
13
‘‘(C) In the case of biological implants that are un-
14
available for procurement under the Federal Supply 
15
Schedules, the Secretary shall procure such implants using 
16
competitive procedures in accordance with applicable law 
17
and the Federal Acquisition Regulation, including through 
18
the use of a national contract. 
19
‘‘(4) In procuring biological implants under this sec-
20
tion, the Secretary shall permit a vendor to use any of 
21
the accredited entities identified by the Food and Drug 
22
Administration as an issuing agency pursuant to section 
23
830.100 of title 21, Code of Federal Regulations, or any 
24
successor regulation. 
25
23:09 Jan 28, 2019
H547
11 
•HR 547 IH
‘‘(5) Section 8123 of this title shall not apply to the 
1
procurement of biological implants. 
2
‘‘(b) PENALTIES.—In addition to any applicable pen-
3
alty under any other provision of law, any procurement 
4
employee of the Department who is found responsible for 
5
a biological implant procurement transaction with intent 
6
to avoid or with reckless disregard of the requirements of 
7
this section shall be ineligible to hold a certificate of ap-
8
pointment as a contracting officer or to serve as the rep-
9
resentative of an ordering officer, contracting officer, or 
10
purchase card holder. 
11
‘‘(c) DEFINITIONS.—In this section: 
12
‘‘(1) The term ‘biological implant’ has the 
13
meaning given that term in section 7330C(d) of this 
14
title. 
15
‘‘(2) The term ‘distinct identifier’ means a dis-
16
tinct identification code that— 
17
‘‘(A) relates a biological implant to the 
18
human donor of the implant and to all records 
19
pertaining to the implant; 
20
‘‘(B) includes information designed to fa-
21
cilitate effective tracking, using the distinct 
22
identification code, from the donor to the recipi-
23
ent and from the recipient to the donor; and 
24
23:09 Jan 28, 2019
H547
12 
•HR 547 IH
‘‘(C) satisfies the requirements of section 
1
1271.290(c) of title 21, Code of Federal Regu-
2
lations, or any successor regulation. 
3
‘‘(3) The term ‘tissue distribution intermediary’ 
4
means an agency that acquires and stores human 
5
tissue for further distribution and performs no other 
6
tissue banking functions. 
7
‘‘(4) The term ‘tissue processor’ means an enti-
8
ty processing human tissue for use in biological im-
9
plants, including activities performed on tissue other 
10
than donor screening, donor testing, tissue recovery 
11
and collection functions, storage, or distribution.’’. 
12
(2) CLERICAL AMENDMENT.—The table of sec-
13
tions at the beginning of chapter 81 is amended by 
14
inserting after the item relating to section 8128 the 
15
following new item: 
16
‘‘8129. Procurement of biological implants.’’. 
(b) EFFECTIVE DATE.—Section 8129 of title 38, 
17
United States Code, as added by subsection (a), shall take 
18
effect on the date that is 180 days after the date on which 
19
the tracking system required under section 7330C(b) of 
20
such title, as added by section 2(a), is implemented. 
21
(c) SPECIAL RULE
FOR CRYOPRESERVED PROD-
22
UCTS.—During the three-year period beginning on the ef-
23
fective date of section 8129 of title 38, United States 
24
Code, as added by subsection (a), biological implants pro-
25
23:09 Jan 28, 2019
H547
13 
•HR 547 IH
duced and labeled before that effective date may be pro-
1
cured by the Department of Veterans Affairs without re-
2
labeling under the standard identification system adopted 
3
or implemented under section 7330C of such title, as 
4
added by section 2(a). 
5
SEC. 4. FUNDING. 
6
No additional funds are authorized to carry out the 
7
requirements of this Act and the amendments made by 
8
this Act. Such requirements shall be carried out using 
9
amounts otherwise authorized. 
10
Æ 
23:09 Jan 28, 2019
H547
